1. Home
  2. PRLB vs ZLAB Comparison

PRLB vs ZLAB Comparison

Compare PRLB & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Proto Labs Inc.

PRLB

Proto Labs Inc.

HOLD

Current Price

$79.64

Market Cap

1.7B

Sector

Industrials

ML Signal

HOLD

Logo Zai Lab Limited

ZLAB

Zai Lab Limited

HOLD

Current Price

$17.96

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRLB
ZLAB
Founded
1999
2013
Country
United States
China
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
2.0B
IPO Year
2011
2017

Fundamental Metrics

Financial Performance
Metric
PRLB
ZLAB
Price
$79.64
$17.96
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
5
Target Price
$53.00
$49.60
AVG Volume (30 Days)
205.6K
968.1K
Earning Date
05-01-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
33.33
38.46
EPS
0.33
N/A
Revenue
N/A
$460,156,000.00
Revenue This Year
$8.56
$9.75
Revenue Next Year
$6.89
$26.03
P/E Ratio
$246.12
N/A
Revenue Growth
N/A
15.33
52 Week Low
$38.48
$15.96
52 Week High
$83.15
$41.20

Technical Indicators

Market Signals
Indicator
PRLB
ZLAB
Relative Strength Index (RSI) 59.54 45.85
Support Level $52.62 $16.78
Resistance Level $83.15 $19.41
Average True Range (ATR) 2.98 0.68
MACD -0.09 0.21
Stochastic Oscillator 65.02 55.79

Price Performance

Historical Comparison
PRLB
ZLAB

About PRLB Proto Labs Inc.

Proto Labs Inc is an on-demand manufacturer of custom parts for prototyping and short-run production. The company offers developers and engineers quick-turn production services to reduce the time to market. The Lab uses injection molding, computer numerical control machining, and 3-D printing, and sheet metal to manufacture custom parts for its clients. The company services clients' needs for prototype solutions, parts for testing procedures, bridge production capabilities during disruptions in manufacturing processes, limited-quantity requests, and end-of-life production support. Geographically, a majority of the company's revenue is derived from the United States and the rest from Europe.

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.

Share on Social Networks: